Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,574,626
+$1,137,446 QoQ
Shares Held
3,814
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,787
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cannell & Spears LLC holds $208,924,357 across 12 Drug Manufacturers - General names. LLY ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
557,332 | $71,617,162 | |
| 2 | ABBV |
AbbVie Inc.
|
255,977 | $64,414,052 | |
| 3 | JNJ |
Johnson & Johnson
|
169,381 | $43,017,692 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
236,705 | $13,638,942 | |
| 5 | PFE |
Pfizer Inc
|
236,223 | $5,688,249 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
3,814 | $4,574,626 | |
| 7 | AMGN |
Amgen Inc
|
8,507 | $3,080,554 | |
| 8 | BIIB |
Biogen Inc.
|
5,083 | $1,098,232 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,574,626 | 3,814 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,437,180 | 3,737 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,040,797 | 3,760 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,897,874 | 3,798 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,072,907 | 3,942 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,249,955 | 3,935 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,031,644 | 3,927 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,485,287 | 3,934 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,897,216 | 3,200 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,332,324 | 2,998 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,309,238 | 2,246 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,152,680 | 2,146 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $1,006,431 | 2,146 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $672,072 | 1,957 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $715,948 | 1,957 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $612,748 | 1,895 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $614,415 | 1,895 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $542,671 | 1,895 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $523,436 | 1,895 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $437,839 | 1,895 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $434,940 | 1,895 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $354,023 | 1,895 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $421,255 | 2,495 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $369,309 | 2,495 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $409,629 | 2,495 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $415,466 | 2,995 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||